FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Felix Schmitt-HoffnerMarcel Kool

Abstract

Clinical outcomes of patients with neuroblastoma range from spontaneous tumor regression to fatality. Hence, understanding the mechanisms that cause tumor progression is crucial for the treatment of patients. In this study, we show that FOXR2 activation identifies a subset of neuroblastoma tumors with unfavorable outcome and we investigate the mechanism how FOXR2 relates to poor outcome in patients. We analyzed three independent transcriptional data sets of in total 1030 primary neuroblastomas with full clinical annotation. We performed immunoprecipitation for FOXR2 and MYCN and silenced FOXR2 expression in two neuroblastoma cell lines to examine the effect on cellular processes, transcriptome, and MYCN protein levels. Tumor samples were analyzed for protein levels of FOXR2 and MYCN. In three combined neuroblastoma data sets, 9% of tumors show expression of FOXR2 but have low levels of MYCN mRNA. FOXR2 expression identifies a group of patients with unfavorable outcome, showing 10-year overall survival rates of 53%-59%, and proves to be an independent prognostic factor compared with established risk factors. Transcriptionally, FOXR2-expressing tumors are very similar to MYCN-amplified tumors, suggesting that they might share a c...Continue Reading

References

Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M Maris, K K Matthay
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Aug 29, 2006·Seminars in Cancer Biology·Marina Vita, Marie Henriksson
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Susan WeeChristoph Lengauer
Jan 30, 2009·Cell Cycle·Dmitri WiederschainJohn D Benson
Jun 19, 2010·The New England Journal of Medicine·John M Maris
May 7, 2011·Bioinformatics·Arthur LiberzonJill P Mesirov
Mar 15, 2012·JAMA : the Journal of the American Medical Association·Nai-Kong V CheungUNKNOWN St Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
Jan 22, 2013·Nature Genetics·Trevor J PughJohn M Maris
Oct 3, 2013·Cold Spring Harbor Perspectives in Medicine·Miller Huang, William A Weiss
Mar 7, 2014·Cancer Research·Hideto KosoSumiko Watanabe
Jun 26, 2015·Genome Biology·Wenqian ZhangMatthias Fischer
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Navin R PintoSusan L Cohn
Oct 16, 2015·Nature·Martin PeiferMatthias Fischer
Nov 3, 2015·Nature Genetics·Linda J ValentijnRogier Versteeg
Nov 26, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Haiping SongTao Huang
Feb 6, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiao WangYandong Li
Jan 10, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Weibo XuXiaodong Li
Sep 17, 2017·Oncotarget·Xuejiao LiuRutong Yu
Nov 2, 2017·Neoplasia : an International Journal for Oncology Research·Carolina RosswogMatthias Fischer
Dec 14, 2018·Science·Sandra AckermannMatthias Fischer
Feb 16, 2020·Nature Communications·Maged ZeineldinMichael A Dyer
Feb 19, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F BertholdT Simon
Apr 16, 2020·Cancer Research·Balakrishna KoneruC Patrick Reynolds

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Haiping SongTao Huang
Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Weibo XuXiaodong Li
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Xiao WangYandong Li
© 2021 Meta ULC. All rights reserved